Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 3

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Lymphoid 3Thoracic 1Sarcoma 1Plasma cell 1Gynecologic 1Genitourinary 1Gastrointestinal 1Breast 1

Conditions

Lymphoma 2Sarcoma 1Prostatic Neoplasms 1Ovarian Neoplasms 1Multiple Myeloma 1Mixed Dementias 1Lymphoma, Follicular 1Lung Neoplasms 1Lewy Body Disease 1Kidney Neoplasms 1Dementia, Vascular 1Dementia 1Colorectal Neoplasms 1Cognitive Dysfunction 1Breast Neoplasms 1

Interventions

Cyclophosphamide 548pembrolizumab 384Radiotherapy 363Bevacizumab 360Carboplatin 351Rituximab 315Cisplatin 300Gemcitabine 297Paclitaxel 288Dexamethasone 272Docetaxel 271fludarabine phosphate 241Doxorubicin 231Nivolumab 220Etoposide 209Cytarabine 203Lenalidomide 201fludarabine 191Oxaliplatin 191Fluorouracil 190Melphalan 189Filgrastim 188Capecitabine 175Calcium Dobesilate 172Radiosurgery 167Erlotinib Hydrochloride 167Methotrexate 163Bortezomib 162Granulocyte Colony-Stimulating Factor 154Whole-Body Irradiation 144

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Has results × Referral and Consultation × Clear all
NCT05860127 2026-03-23

Cognitive Stimulation Therapy for Dementia: A Two-Armed Pragmatic Trial

University of Massachusetts, Amherst

Phase NA Completed
133 enrolled 14 charts
Lymphoid

Mixed Dementias, Dementia, Lymphoma, Follicular, Dementia, Vascular, Lewy Body Disease, Cognitive Dysfunction

NCT06063603 2025-09-18

ASCENT

Mayo Clinic

Phase NA Completed
51 enrolled 8 charts
LymphoidPlasma cell

Lymphoma, Multiple Myeloma

NCT02821793 2025-07-01

PRIORITY

Institut Bergonié

Completed
346 enrolled 9 charts
BreastGastrointestinalGenitourinaryGynecologicLymphoidSarcomaThoracic

Breast Neoplasms, Kidney Neoplasms, Lung Neoplasms, Lymphoma, Ovarian Neoplasms, Prostatic Neoplasms, Sarcoma, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡